BGLAP and metabolic dysfunction-associated steatotic liver disease: Osteocalcin subgroup analysis by regional category showed that Asians individuals with NAFLD had significantly lower osteocalcin levels than the control group (SMD: −0.16; 95% CI: −0.23–−0.09; and I2 = 99.1%), and there were no significant difference in those living in Europe (Figure 2(a)).